Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Sangamo Therapeutics First Quarter 2024 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics Inc (SGMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 16,958,477 | $11,365,571 | 0.15% | |
| 2. | D E Shaw D. E. Shaw | 3,067,435 | $2,055,795 | -35% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,428,255 | $957,217 | -32% | 0% |
| 4. | Hudson Bay Capital Management Sander Gerber | 1,373,500 | $920,520 | -46% | 0% |
| 5. | Millennium Management Israel Englander | 1,104,877 | $740,489 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.69 | 6,784 | Director | 32,484 | 2022-06-03 | Filing | |
| $3.60 | 5,000 | Director | 48,700 | 2022-06-01 | Filing | |
| $5.20 | 3,000 | Director | 13,000 | 2020-03-18 | Filing | |
| $4.99 | 5,000 | Director | 30,000 | 2020-03-17 | Filing | |
| $5.67 | 5,000 | Director | 25,000 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.50 | 6,000,000 | Large Shareholder | 17,652,466 | 2023-09-26 | Filing | |
| $5.27 | 100,000 | Large Shareholder | 23,652,466 | 2022-08-30 | Filing | |
| $5.33 | 400,000 | Large Shareholder | 23,752,466 | 2022-08-29 | Filing | |
| $8.51 | 2,764 | Large Shareholder | 24,152,466 | 2021-12-28 | Filing | |
| $8.56 | 600 | Large Shareholder | 24,155,230 | 2021-12-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,095,865 | $7,658,282 | 0% | |
| 2. | 12,599,129 | $6,845,107 | 0% | |
| 3. | 12,397,924 | $6,735,792 | 0.03% | |
| 4. | 3,206,310 | $1,742,178 | 0% | |
| 5. | 2,708,368 | $1,471,456 | 0% |
News See All
5 Hot Penny Stock On the Move
Applied Therapeutics Inc (NASDAQ:APLT) shares jumped about 79% over the past five days through February 22.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Sangamo Second Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Sangamo First Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you, for standing by. Welcome to the Sangamo Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Gene Editing Stocks To Buy
A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
Were Hedge Funds Right About Selling Sangamo Therapeutics, Inc. (SGMO)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Wasatch Global on Sangamo (SGMO): "We Remain Optimistic About its Future Prospects"
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
